Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3225 SEK | -2.27% | -19.07% | -67.42% |
Apr. 24 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
Apr. 24 | Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 17.12M 1.61M | Sales 2025 * | 36.71M 3.44M | Capitalization | 86.28M 8.09M |
---|---|---|---|---|---|
Net income 2024 * | -69M -6.47M | Net income 2025 * | -57M -5.35M | EV / Sales 2024 * | -1.27 x |
Net cash position 2024 * | 108M 10.13M | Net cash position 2025 * | 35M 3.28M | EV / Sales 2025 * | 1.4 x |
P/E ratio 2024 * |
-1.55
x | P/E ratio 2025 * |
-1.72
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.73% |
1 day | -2.27% | ||
1 week | -19.07% | ||
Current month | -11.03% | ||
1 month | -12.36% | ||
3 months | -64.05% | ||
6 months | -72.53% | ||
Current year | -67.42% |
Managers | Title | Age | Since |
---|---|---|---|
Pål Ryfors
CEO | Chief Executive Officer | 41 | 15-12-13 |
Patrick Jamnik
PSD | President | 41 | 20-12-31 |
Veronica Wallin
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laura Shunk
BRD | Director/Board Member | 67 | 17-05-21 |
Ulf Grunander
CHM | Chairman | 70 | 21-04-30 |
Director/Board Member | 62 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.3225 | -2.27% | 932,443 |
24-05-23 | 0.33 | -10.69% | 2,241,965 |
24-05-22 | 0.3695 | +0.14% | 316,414 |
24-05-21 | 0.369 | -4.77% | 185,884 |
24-05-20 | 0.3875 | -2.76% | 199,872 |
Delayed Quote Nasdaq Stockholm, May 24, 2024 at 11:29 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.42% | 8.1M | |
+12.05% | 128B | |
-9.24% | 10.88B | |
+0.29% | 8.76B | |
+36.99% | 5.48B | |
-21.98% | 4.72B | |
+8.02% | 3.43B | |
-10.32% | 2.76B | |
-12.33% | 2.06B | |
-13.53% | 1.92B |
- Stock Market
- Equities
- EPIS B Stock